Hexarelin CJC-1295 DAC Stack Peptide Vials
Hexarelin CJC-1295 DAC Stack is a laboratory research material supplied in individual vial (2mg Hexarelin and 2mg CJC-1295 DAC) containing the specified peptide compounds for controlled laboratory research, analytical investigation, and scientific research purposes.
$48.48
Spend $250.00 for 7.5% off on qualifying items · Applied automatically at checkout
434 in stock
Researchers who bought Hexarelin CJC-1295 DAC Stack Peptide Vials also bought
Hexarelin CJC-1295 DAC Stack Peptide Vials
Hexarelin CJC-1295 DAC Stack contains two synthetic peptide compounds associated with scientific research into growth hormone signaling. Hexarelin is classified as a synthetic growth hormone-releasing hexapeptide, while CJC-1295 with DAC is a long-acting analog of growth hormone-releasing hormone (GHRH). Both compounds have appeared in published research examining growth hormone-related endocrine activity. Direct SARMs Greece supplies the stack as a laboratory research material in sterile glass vials containing lyophilized powder. Where applicable, researchers may review analytical documentation, including a Certificate of Analysis (COA) and HPLC purity report, before using the stack in their research.
Benefits of the vial format
Visit Hexarelin Research Hub ▸
Visit CJC-1295 DAC Research Hub. ▸
HEXARELIN CJC-1295 DAC is supplied exclusively for laboratory research use. The information on this page is provided for scientific and educational reference and is based on available published research. This product is not intended for human or veterinary use, diagnosis, treatment, or prevention of any disease or medical condition. It is intended solely for qualified laboratory research and must be handled in accordance with applicable laboratory safety requirements.
Buy Hexarelin CJC-1295 DAC Stack Peptide Vials Greece from Direct SARMS.
Additional information
| Size | 2 mg |
| Purity | 99.5% |
| Molecular Formula | C47H58N12O6 |
| Molecular Weight | 887.04 g/mol |
| Sequence | H-His-D-Trp(2-Me)-Ala-Trp-D-Phe-Lys-NH2 |
| Physical Form | White or almost white lyophilized powder |
| Size | 2 mg |
| Purity | 98.7% |
| Molecular Formula | C159H258N46O45 |
| Molecular Weight | 3647.65 g/mol |
| Sequence | H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 |
| Physical Form | White or almost white lyophilized powder |
General information
Applies to all Direct Sarms research compounds unless noted otherwise on the product.
Storage & handling
Store the sealed lyophilised vial as stated on the product label. Once reconstituted, refrigerate and keep away from light. Do not refreeze a reconstituted solution.
Shipping & discretion
Fully tracked dispatch with worldwide shipping available. Sent in plain, discreet outer packaging with no product description on the label.
FDA disclosure & intended use
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Research use only — not for human or animal consumption. You must be 18+ and a qualified researcher.
Got a question about this HEXARELIN CJC-1295 DAC compound?
A stack of vials containing the research peptides Hexarelin and CJC-1295 DAC is a product designed for research purposes and includes two different peptide compounds which are supplied in a single vial for use in a laboratory setting. The two peptides have already been studied separately in scientific research concerning peptide signalling and molecular pathways. This product is for research use only and is not to be consumed by humans.
CJC-1295 DAC and CJC-1295 without DAC are different research variants which have distinct molecular characteristics; the DAC component is a structural feature that sets this variant apart from the no DAC versions. Researchers should consider each CJC-1295 variant separately when making their evaluation, taking into account the available scientific literature and the experimental requirements.
A vial stack format enables researchers to study two different peptide compounds at the same time within a controlled laboratory research setting. The combination of Hexarelin and CJC-1295 DAC has not resulted in a validated result, obtained approval, or been established as suitable for use in humans. Research using these substances should adhere to the relevant laboratory procedures and guidelines.
Hexarelin and CJC-1295 DAC are different peptides which have different sequences, structures, and backgrounds in scientific research. Even though both have been investigated in the context of peptide biology and signalling pathways, they are separate substances and therefore the scientific information about them should be examined separately.
No, this product is solely provided for use in laboratory research and is not meant for human consumption, for clinical use, for medical applications, for therapeutic use, or as a dietary supplement. The product does not include any dosing instructions, administration advice, or recommendations regarding its use in humans.
Certificate of Analysis
| Identity | HEXARELIN CJC-1295 DAC | CONFORMS |
| Purity (HPLC) | 98.7% | CONFORMS |
| Mass (LC-MS) | 3647.65 g/mol | CONFORMS |
| Appearance | White or almost white lyophilized powder | CONFORMS |







